<sup>18</sup>F-DCFPyL PET/CT for Initially Diagnosed and Biochemically Recurrent Prostate Cancer: Prospective Trial with Pathologic Confirmation-Reference-Cited by-同舟云学术

¹⁸F-DCFPyL PET/CT for Initially Diagnosed and Biochemically Recurrent Prostate Cancer: Prospective Trial with Pathologic Confirmation

Published:2022-11 Issue:2 Volume:305 Page:419-428
ISSN:0033-8419
Container-title:Radiology
language:en
Short-container-title:Radiology

Author:

Ulaner Gary A.^ORCID,Thomsen Beth^ORCID,Bassett Jeffrey,Torrey Robert,Cox Craig,Lin Kevin^ORCID,Patel Trushar^ORCID,Techasith Tust^ORCID,Mauguen Audrey^ORCID,Rowe Steven P.^ORCID,Lindenberg Liza^ORCID,Mena Esther,Choyke Peter^ORCID,Yoshida Jeffrey

Publisher

Radiological Society of North America (RSNA)

Subject

Radiology, Nuclear Medicine and imaging

Link

http://pubs.rsna.org/doi/pdf/10.1148/radiol.220218

Reference29 articles.

1. Prostate cancer–specific PET radiotracers: A review on the clinical utility in recurrent disease

2. Prostate-specific Membrane Antigen PET in Prostate Cancer

3. 2-(3-{1-Carboxy-5-[(6-[18F]Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostate Cancer

4. Initial Evaluation of [18F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer

5. PSMA-Based [18F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PPV of Bone Uptake of ¹⁸F-Flotufolastat: Evaluation Using SPOTLIGHT Study Data;American Journal of Roentgenology;2024-09-04

2. Prostate Cancer Recurrence: Examining the Role of Salvage Radiotherapy Field and Risk Factors for Regional Disease Recurrence Captured on 18F-DCFPyL PET/CT;Clinical Genitourinary Cancer;2024-08

3. ER-Targeted PET for Initial Staging and Suspected Recurrence in ER-Positive Breast Cancer;JAMA Network Open;2024-07-26

4. Enhancing prostate cancer diagnosis and reducing unnecessary biopsies with [18F]DCFPyL PET/CT imaging in PI-RADS 3/4 patients;Scientific Reports;2024-07-05

5. Novel [⁶⁸Ga/¹⁷⁷Lu]Ga/Lu-AZ-093 as PSMA-Targeting Agent for Diagnosis and Radiotherapy;Molecular Pharmaceutics;2024-06-10